We are live on ! Find out more
NA

Navellier & Associates Portfolio holdings

AUM $960M
1-Year Est. Return 79.37%
This Fund
S&P 500
This Quarter Est. Return
+17.85%
1 Year Est. Return
+79.37%
3 Year Est. Return
+262.34%
5 Year Est. Return
+412.53%
10 Year Est. Return
+2,309.54%
AUM
$986M
AUM Growth
+$179M
Cap. Flow
+$89.4M
Cap. Flow %
9.07%
Top 10 Hldgs %
27.52%
Holding
384
New
77
Increased
211
Reduced
33
Closed
30

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$9.42M
2
ACM icon
Aecom
ACM
+$5.27M
3
VRSN icon
VeriSign
VRSN
+$4.89M
4
UI icon
Ubiquiti
UI
+$4.68M
5
AS icon
Amer Sports
AS
+$4.58M

Sector Composition

Rank Sector Weight
1 Technology 26.19%
2 Industrials 21.9%
3 Consumer Staples 8.6%
4 Healthcare 8.37%
5 Consumer Discretionary 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EAT icon
101
Brinker International
EAT
$9.52B
$2.34M 0.24%
18,491
+3,771
+26% +$589K
TLN
102
Talen Energy Corp
TLN
$16.4B
$2.27M 0.23%
5,326
+2,075
+64% +$750K
EFV icon
103
iShares MSCI EAFE Value ETF
EFV
$29B
$2.26M 0.23%
33,333
MSTR icon
104
Strategy Inc
MSTR
$34.8B
$2.26M 0.23%
7,011
+883
+14% +$328K
BAH icon
105
Booz Allen Hamilton
BAH
$8.59B
$2.16M 0.22%
21,639
+308
+1% +$32.9K
HCI icon
106
HCI Group
HCI
$2.28B
$2.14M 0.22%
11,169
+605
+6% +$95.8K
WWD icon
107
Woodward
WWD
$21.4B
$2.13M 0.22%
8,447
+244
+3% +$60.6K
FBT icon
108
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.71B
$2.09M 0.21%
+11,658
New +$1.99M
PAHC icon
109
Phibro Animal Health
PAHC
$1.48B
$2.09M 0.21%
51,626
+7,855
+18% +$259K
CMCL icon
110
Caledonia Mining Corp
CMCL
$362M
$2.05M 0.21%
+56,530
New +$1.44M
FXH icon
111
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$2.04M 0.21%
+18,614
New +$1.95M
SPY icon
112
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$2.01M 0.2%
3,022
+125
+4% +$80.1K
CVX icon
113
Chevron
CVX
$383B
$2.01M 0.2%
12,940
+811
+7% +$126K
FXN icon
114
First Trust Energy AlphaDEX Fund
FXN
$375M
$2.01M 0.2%
+123,052
New +$1.96M
IESC icon
115
IES Holdings
IESC
$14.3B
$1.99M 0.2%
4,999
+2,068
+71% +$712K
GRMN
116
Garmin
GRMN
$58.6B
$1.96M 0.2%
7,976
+303
+4% +$69.9K
EGO icon
117
Eldorado Gold
EGO
$8.26B
$1.94M 0.2%
66,990
+4,404
+7% +$104K
NEE icon
118
NextEra Energy
NEE
$179B
$1.87M 0.19%
24,785
+2,576
+12% +$188K
SRAD icon
119
Sportradar
SRAD
$3.65B
$1.87M 0.19%
69,406
+10,676
+18% +$317K
FLS icon
120
Flowserve
FLS
$9.76B
$1.85M 0.19%
34,771
+376
+1% +$20.4K
DX
121
Dynex Capital
DX
$3.16B
$1.82M 0.18%
147,734
+11,210
+8% +$140K
MCD icon
122
McDonald's
MCD
$191B
$1.81M 0.18%
5,940
+895
+18% +$272K
REVG
123
DELISTED
REV Group
REVG
$1.8M 0.18%
31,760
+12,866
+68% +$683K
NAGE
124
Niagen Bioscience
NAGE
$273M
$1.77M 0.18%
189,534
+37,461
+25% +$378K
CVSA
125
Covista Inc
CVSA
$4.31B
$1.76M 0.18%
11,405
+4,982
+78% +$638K

Similar funds

Navellier & Associates's Q3 2025 Portfolio in Review

As of Q3 2025, Navellier & Associates held 384 positions worth $986M, up 22% from $807M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Navellier & Associates deployed $89.4M of net new capital in Q3 2025, opening 77 new positions and adding to 211 existing holdings. Its largest new stake was VeriSign: 17,491 shares worth $4.89M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Progressive, an estimated $3.54M trimmed.

  • Navellier & Associates's largest Q3 2025 buy was VeriSign: 17,491 shares worth $4.89M.
  • Navellier & Associates added most to ExxonMobil in Q3 2025, an estimated $9.42M increase.
  • Navellier & Associates's biggest Q3 2025 reduction was Progressive, cutting an estimated $3.54M.
  • Navellier & Associates fully exited iShares 20+ Year Treasury Bond ETF in Q3 2025, selling an estimated $5.78M.
  • Navellier & Associates's ten largest holdings make up 28% of its $986M portfolio in Q3 2025.
  • Navellier & Associates opened 77 new positions and closed 30 in Q3 2025.
  • Navellier & Associates's portfolio value rose 22% quarter-over-quarter to $986M.

Based on Navellier & Associates's 13F filing for Q3 2025, filed 6 Nov 2025.